Global study reveals HIV resistance patterns to key drug
NCT ID NCT06285110
First seen Nov 26, 2025 · Last updated May 23, 2026 · Updated 23 times
Summary
This study enrolled over 1,100 people living with HIV whose current dolutegravir-based treatment was failing (viral load over 1,000 copies/mL). Researchers collected blood samples and sequenced the virus's entire genome to identify which drug-resistance mutations were present. The goal was to understand how different HIV subtypes develop resistance, helping doctors choose better treatments in the future.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
ACONDA Centre de Prise en Charge et de Formation (CePReF)
Abidjan, Côte d’Ivoire
-
Centre de Traitement Ambulatoire
Brazzaville, Republic of the Congo
-
Centre de Traitement Ambulatoire
Pointe-Noire, Republic of the Congo
-
Centre for Infectious Disease Research Zambia (CIDRZ)
Lusaka, Zambia
-
Centre médical de suivi des donneurs de sang, CNTS
Abidjan, Côte d’Ivoire
-
Centro Medico Huesped
Buenos Aires, Argentina
-
HIV-NAT/Thai Red Cross AIDS Research Center (TRCARC)
Bangkok, Thailand
-
Hopital de Jour du Centre Hospitalier Universitaire (CHU Souro Sanou)
Bobo-Dioulasso, Burkina Faso
-
Hospital Jamot
Yaoundé, Cameroon
-
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
Mexico City, Mexico
-
Instituto Nacional de Infectiologia Evandro Chagas - Fiocruz
Rio de Janeiro, Brazil
-
Lighthouse clinic
Lilongwe, Malawi
-
Martin Preuss Centre
Lilongwe, Malawi
-
Masaka Regional Referral Hospital / AHF Uganda Cares
Masaka, Uganda
-
Mbarara University of Science and Technology / Mbarara ISS Clinic (MUST)
Mbarara, Uganda
-
Moi University, AMPATH
Eldoret, Kenya
-
National Centre for HIV/AIDS, Dermatology and STDs (NCHADS)
Phnom Penh, Cambodia
-
National Institute for Medical Research (NIMR)
Kisesa, Tanzania
-
Newlands Clinic
Harare, Zimbabwe
-
Ramathibodi Hospital, Mahidol University
Bangkok, Thailand
-
Regional Hospital Limbe
Limbe, Cameroon
-
Research for Development, Einstein-Rwanda Research and Capacity Building Program
Kigali, Rwanda
Conditions
Explore the condition pages connected to this study.